{
  "paper": {
    "doi": null,
    "pmcid": "extracted",
    "title": "The DDR-immune fitness score: a biomarker for guiding parp and immunotherapy synergy in extensive-stage small cell lung cancer",
    "authors": [
      "Not specified"
    ],
    "journal": "Not specified",
    "year": 2024,
    "study_type": "biomarker development",
    "eco_type": "systematic review and validation study"
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "39f1b7e43865f4ea820908097aed6859daeae7cf",
      "git_commit_short": "39f1b7e",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T18:22:22.142779Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 43.21
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "disease_1",
      "class": "Disease",
      "name": "extensive-stage small-cell lung cancer",
      "synonyms": [
        "ES-SCLC",
        "extensive-stage SCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0149925",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_1",
      "class": "Biomarker",
      "name": "DDR-Immune Fitness score",
      "synonyms": [
        "DDR-IF score",
        "DDR-IF"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_1",
      "class": "Drug",
      "name": "PARP inhibitor",
      "synonyms": [
        "PARPi",
        "PARP inhibitors"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1298331",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_2",
      "class": "Drug",
      "name": "immune checkpoint blocker",
      "synonyms": [
        "ICB",
        "immune checkpoint blockers"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_1",
      "class": "Gene",
      "name": "BRCA1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1100",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_2",
      "class": "Gene",
      "name": "BRCA2",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1101",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_3",
      "class": "Gene",
      "name": "ATM",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:795",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_4",
      "class": "Gene",
      "name": "PARP1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:270",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_5",
      "class": "Gene",
      "name": "RAD51",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9817",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_6",
      "class": "Gene",
      "name": "PD-L1",
      "synonyms": [
        "CD274"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:17635",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_7",
      "class": "Gene",
      "name": "STING",
      "synonyms": [
        "TMEM173"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:27962",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_8",
      "class": "Gene",
      "name": "SLFN11",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:20556",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_2",
      "class": "Biomarker",
      "name": "homologous recombination deficiency",
      "synonyms": [
        "HRD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_3",
      "class": "Biomarker",
      "name": "tumor mutational burden",
      "synonyms": [
        "TMB"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pathway_1",
      "class": "Pathway",
      "name": "DNA damage repair pathway",
      "synonyms": [
        "DDR pathway"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "pathway_2",
      "class": "Pathway",
      "name": "cGAS-STING pathway",
      "synonyms": [
        "STING pathway"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_3",
      "class": "Drug",
      "name": "olaparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1597582",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_4",
      "class": "Drug",
      "name": "durvalumab",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1876435",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_5",
      "class": "Drug",
      "name": "talazoparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "2058257",
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_6",
      "class": "Drug",
      "name": "niraparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": "1876308",
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "extracted:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted",
      "text_span_id": "results_1",
      "text": "DDR-IF-high tumors were characterized by a distinct biological profile, including (i) transcriptional exhaustion of the cGAS-STING innate immune pathway (p < 0.001), (ii) significantly reduced CD8+ T cell infiltration (2.3-fold fewer, p = 0.004), and (iii) a superior pooled objective response rate to PARP-ICB combinations (42% vs 18%; risk ratio 2.3, 95% CI 1.3-4.2; p = 0.003).",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": "systematic review and validation study",
      "source": "extracted"
    },
    {
      "id": "extracted:methods:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted",
      "text_span_id": "methods_2",
      "text": "The score, constructed using elastic-net regression, incorporates homologous recombination deficiency (HRD), tumor mutational burden (TMB), and STING pathway activity.",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": "systematic review and validation study",
      "source": "extracted"
    },
    {
      "id": "extracted:results:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted",
      "text_span_id": "results_3",
      "text": "In the independent MSK-IMPACT validation cohort (n=152), the DDR-IF score successfully stratified patients, with DDR-IF-high status being associated with significantly improved progression-free survival on PARP-ICB regimens (HR 0.45, 95% CI 0.22-0.91).",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": "systematic review and validation study",
      "source": "extracted"
    },
    {
      "id": "extracted:background:4:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "extracted",
      "text_span_id": "background_4",
      "text": "Recent global epidemiological data (2024) confirm that more than 70% of ES-SCLC cases carry at least one actionable DDR defect, with frequent alterations in genes such as ATM (11.2%) and BRCA1/2 (6.7%).",
      "confidence": 0.85,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": "systematic review and validation study",
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "biomarker_1",
      "predicate": "INDICATES",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:results:1:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.95,
      "properties": {
        "response_rate": "42% vs 18%",
        "risk_ratio": "2.3 (95% CI 1.3-4.2)"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "drug_1",
      "predicate": "TREATS",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:results:1:llm",
        "extracted:results:3:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "combination_therapy": "with immune checkpoint blockers",
        "hazard_ratio": "0.45 (95% CI 0.22-0.91)"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "drug_2",
      "predicate": "TREATS",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:results:1:llm",
        "extracted:results:3:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "combination_therapy": "with PARP inhibitors"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_2",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_1",
      "evidence_ids": [
        "extracted:methods:2:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "component_weight": "0.4"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_3",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_1",
      "evidence_ids": [
        "extracted:methods:2:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "component_weight": "0.35"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "pathway_2",
      "predicate": "ASSOCIATED_WITH",
      "object": "biomarker_1",
      "evidence_ids": [
        "extracted:methods:2:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.9,
      "properties": {
        "component_weight": "0.25"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_3",
      "predicate": "ASSOCIATED_WITH",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:background:4:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "11.2%"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:background:4:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_2",
      "predicate": "ASSOCIATED_WITH",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:background:4:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.85,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "pathway_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "disease_1",
      "evidence_ids": [
        "extracted:background:4:llm"
      ],
      "source_papers": [
        "extracted"
      ],
      "confidence": 0.85,
      "properties": {
        "defect_frequency": ">70%"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "The DDR-IF score is described as exploratory and requires prospective validation in multicenter trials",
    "The study integrated data from 6 phase II trials and 82 SCLC tumor samples",
    "DDR-IF-high tumors showed cGAS-STING pathway exhaustion and reduced CD8+ T cell infiltration"
  ]
}